MoneyWorks4Me

Wockhardt informs about press release

16 Mar 2022 Evaluate

Wockhardt has informed that it enclosed a Press Release titled ‘National Institutes of Health (NIH), USA to conduct human Phase 1 trial of Wockhardt’s novel once-a-day MDR Gram-negative antibiotic WCK 6777’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1786.60
Dr. Reddys Labs. 1198.50
Cipla 1335.80
Lupin 2012.05
Zydus Lifesciences 1141.00
View more..